NEUROPACE, INC. Retained Earnings
NEUROPACE, INC. (NPCE) had Retained Earnings of -$565.30 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-11
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$565.30M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$559.10M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$552.41M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$549.69M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$565.30M 10-Q · filed 2026-08-11 |
| 2026-03-31 | -$559.10M 10-Q · filed 2026-05-12 |
| 2025-12-31 | -$552.41M 10-Q · filed 2026-08-11 |
| 2025-09-30 | -$549.69M 10-Q · filed 2025-11-04 |
| 2025-06-30 | -$546.19M 10-Q · filed 2025-08-12 |
| 2025-03-31 | -$537.54M 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$530.95M 10-K · filed 2026-03-03 |
| 2024-09-30 | -$525.70M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$520.25M 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$512.73M 10-Q · filed 2024-05-08 |
| 2023-12-31 | -$503.81M 10-K · filed 2025-03-04 |
| 2023-09-30 | -$497.61M 10-Q · filed 2023-11-06 |
| 2023-06-30 | -$490.35M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$481.23M 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$470.85M 10-K · filed 2024-03-05 |
| 2022-09-30 | -$459.71M 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$447.92M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$435.23M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$423.77M 10-K · filed 2023-03-02 |
| 2021-09-30 | -$413.08M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$405.00M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$396.50M 10-Q · filed 2021-06-03 |
| 2020-12-31 | -$387.69M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |